glp 1 news GLP-1 receptor agonists show promise in treating substance use disorders Alarming rise in weight loss

The lead authors of the study are Mahesh Umapathysivam, MBBS, DPhil, an endocrinologist and clinical researcher at Adelaide University in Australia and a former trainee with Gloyn, and Elisa Araldi, PhD, associate professor of medicine and surgery at the University of Parma in Italy and a former trainee with Stoffel

The short answer: You can begin with your primary care clinician, a specialist in obesity medicine, or in some cases a telehealth provider

For the newer GLP-1 medications, it would be useful to look at whether there are genetic variants, like the variants in PAM, that explain poor responders to their medications. For now, the mechanism driving GLP-1 resistance remains unresolved, but it is likely complex and multifactorial, Gloyn said

only 43% of participants met the lower end of this g/kg/day recommendation

Weight affected almost every aspect of her health and her quality of life

Who can prescribe GLP-1 medications